Stay updated on Lumateperone Adjunct in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.

Latest updates to the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record for a completed Phase 3 trial of lumateperone as adjunctive treatment for major depressive disorder is displayed, including participant criteria, study design and outcomes, and locations. It also shows related publications, record dates, and study documents.SummaryDifference67%

- Check20 days agoChange DetectedThe page continues to display a 403 Forbidden error instead of the study record. The footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide notice announces updates and FAQs about NIH websites and a federal shift from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check34 days agoChange DetectedThe site revision label in the footer changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1 while the 403 error page remains otherwise unchanged.SummaryDifference0.2%

- Check62 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details. The page displays the site header and a minimal error message, indicating access is blocked.SummaryDifference17%

Stay in the know with updates to Lumateperone Adjunct in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.